Graph Neural Network (GNN)
A class of neural network architectures designed to process graph-structured data by aggregating information from neighboring nodes. Graph neural networks are widely applied in areas such as molecular property prediction, drug discovery, and social network analysis.
Timeline (last 90 days)
Among molecular representation methods, SMILES strings are compact and can be directly fed to language models, but they are not unique and are insensitive to subtle structural changes; molecular fingerprints (such as ECFP/Morgan fingerprints) are suited to similarity search and traditional machine learning but lose topological details; graph neural networks treat atoms as nodes and chemical bonds as edges and are the current mainstream approach for molecular property prediction and generation.
GNNs address the problems in graph data of a non-fixed number of neighbors and meaningless ordering through the message passing mechanism: in each layer, a node first aggregates the feature information of its neighbors, then combines it with its own representation and updates it through a nonlinear transformation.
Part 3 graph machine learning covers traditional methods and feature engineering on graphs, shallow node embeddings, knowledge graph embeddings, graph neural networks, and subgraph sampling.
The message-passing mechanism originates from the graph neural network (GNN) field and refers to an iterative mechanism in which nodes encode information, pass it to neighboring nodes, and then aggregate and update.
GridSFM models the power grid as a graph, treating buses as vertices and transmission lines as edges, using an attention module to handle grid structure, and possesses topology-agnostic capability.
Graph neural network-based methods have been used for the screening of novel antibiotic candidate molecules.
The concept of over-squashing was formally introduced by Alon and Yahav in 2021 in the context of graph neural networks, describing the problem of long-range information being exponentially diluted or lost during propagation.
Graph Neural Networks (GNNs) are deep learning models specifically designed for graph-structured data; molecules can be represented as atom-bond graphs, making GNNs one of the mainstream architectures for molecular property prediction.
Key focus areas in AI-assisted drug discovery (AIDD) include target identification, virtual screening, molecular property prediction, activity prediction, ADMET prediction, and molecular generation and optimization, and practitioners will work with RDKit, molecular descriptors, machine learning, and graph neural networks.
The node inference approach of Relation Networks or graph neural networks holds that when the attributes of a single node are insufficiently certain, information from its neighboring nodes can provide reverse constraints.
13 more timeline events
All Facts (20)
Among molecular representation methods, SMILES strings are compact and can be directly fed to language models, but they are not unique and are insensitive to subtle structural changes; molecular fingerprints (such as ECFP/Morgan fingerprints) are suited to similarity search and traditional machine learning but lose topological details; graph neural networks treat atoms as nodes and chemical bonds as edges and are the current mainstream approach for molecular property prediction and generation.
50%UnverifiedGNNs address the problems in graph data of a non-fixed number of neighbors and meaningless ordering through the message passing mechanism: in each layer, a node first aggregates the feature information of its neighbors, then combines it with its own representation and updates it through a nonlinear transformation.
50%UnverifiedPart 3 graph machine learning covers traditional methods and feature engineering on graphs, shallow node embeddings, knowledge graph embeddings, graph neural networks, and subgraph sampling.
50%UnverifiedThe message-passing mechanism originates from the graph neural network (GNN) field and refers to an iterative mechanism in which nodes encode information, pass it to neighboring nodes, and then aggregate and update.
50%UnverifiedGridSFM models the power grid as a graph, treating buses as vertices and transmission lines as edges, using an attention module to handle grid structure, and possesses topology-agnostic capability.
50%UnverifiedGraph neural network-based methods have been used for the screening of novel antibiotic candidate molecules.
50%UnverifiedThe concept of over-squashing was formally introduced by Alon and Yahav in 2021 in the context of graph neural networks, describing the problem of long-range information being exponentially diluted or lost during propagation.
50%UnverifiedGraph Neural Networks (GNNs) are deep learning models specifically designed for graph-structured data; molecules can be represented as atom-bond graphs, making GNNs one of the mainstream architectures for molecular property prediction.
50%UnverifiedKey focus areas in AI-assisted drug discovery (AIDD) include target identification, virtual screening, molecular property prediction, activity prediction, ADMET prediction, and molecular generation and optimization, and practitioners will work with RDKit, molecular descriptors, machine learning, and graph neural networks.
50%UnverifiedThe node inference approach of Relation Networks or graph neural networks holds that when the attributes of a single node are insufficiently certain, information from its neighboring nodes can provide reverse constraints.
50%UnverifiedGraph Neural Networks (GNNs) bind the topological structure of a graph together with the linear transformation of feature vectors.
50%UnverifiedThe upper bound on the expressive power of GNNs is closely related to the graph isomorphism problem, and the Weisfeiler-Leman (WL) graph isomorphism test provides a theoretical framework for characterizing the expressive power of GNNs.
50%UnverifiedGraph Neural Networks (GNNs) can directly handle non-Euclidean data such as molecular structures, knowledge graphs, and social networks by performing message passing and aggregation on graph structures.
50%UnverifiedSpecialized AI models for antimicrobial peptide discovery are typically based on graph neural networks or protein language models (such as the ESM series), trained on known antimicrobial peptide sequences and activity data.
50%UnverifiedMolecular generation and optimization can leverage graph neural networks (GNN), variational autoencoders (VAE), or diffusion models to generate entirely new molecular structures with specific properties.
50%UnverifiedAI fuzzy matching uses NLP technology to parse unstructured merchant names, matches transaction descriptions via vector similarity computation, and can use graph neural networks to model multi-party transaction relationships.
50%UnverifiedAI fuzzy matching leverages NLP techniques to parse unstructured merchant names, uses vector similarity calculations to match transaction descriptions, and employs graph neural networks to model multi-party transaction relationships.
50%UnverifiedProteinMPNN uses a message-passing neural network to predict the optimal amino acid sequence given a backbone structure, solving the inverse folding problem.
50%UnverifiedNext-generation protein design tools such as RFdiffusion and ProteinMPNN employ advanced architectures including diffusion models and graph neural networks
50%UnverifiedGraph neural network architectures such as GraphSAGE and GAT have demonstrated capabilities in scenarios including social network analysis and molecular property prediction.
50%